DOES THE SCALE SAME-TT2R2 FUNCTIONS IN REAL CLINICAL PRACTICE?
- Authors: Minushkina L.O.1,2, Azizova A.G2, Voskresenskaya T.V2
-
Affiliations:
- The Central state medical Academy of the Administration of the President of the Russian Federation
- The Polyclinic № 2 of the Administration of the President of the Russian Federation
- Issue: Vol 24, No 2 (2018)
- Pages: 65-68
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38430
- DOI: https://doi.org/10.18821/0869-2106-2018-24-2-65-68
- ID: 38430
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Larisa O. Minushkina
The Central state medical Academy of the Administration of the President of the Russian Federation; The Polyclinic № 2 of the Administration of the President of the Russian Federation
Email: minushkina@mail.ru
doctor of medical sciences, professor of the chair of therapy, cardiology and functional diagnostic with the course of nephrology «The Central State Medical Academy» of the Administration of the President of the Russian Federation, 121359, Moscow 121359, Moscow, Russian Federation; 119146, Moscow, Russian Federation
A. G Azizova
The Polyclinic № 2 of the Administration of the President of the Russian Federation119146, Moscow, Russian Federation
T. V Voskresenskaya
The Polyclinic № 2 of the Administration of the President of the Russian Federation119146, Moscow, Russian Federation
References
- Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016; 37(38): 2893-962.
- Rosendaal F.R., Cannegieter S.C., van der Meer F.J., Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb. Haemost. 1993; 69(3): 236-9.
- Apostolakis S., Sullivan R.M., Olshansky B., Lip G.Y.H. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest. 2013; 144(5): 1555-63.
- Zulkifly H., Lip G.Y.H., Lane D.A. Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients treated with vitamin K antagonists: A review. Heart Rhythm. 2017; Pii: S1547-5271(17)31366-8.
- Liu J., Wang N., Qin L., Liu J., Xi S., Wang X., et al. Integrating genotypes in the SAMe-TT2R2 score for the prediction of anticoagulation control in Chinese patients with atrial fibrillation on warfarin. Int. J. Cardiol. 2017; 241: 358-63.
- Bryk A.H., Plens K., Undas A. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation. Cardiol. J. 2017; 24(5): 477-83.
- Lip G.Y., Waldo A.L., Ip J., Martin D.T., Bersohn M.M., Choucair W.K., et al. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT). Am. J. Cardiol. 2016; 118(11): 1680-4.
- Guo Y., Chen Y., Lane D.A., Liu L., Wang Y., Lip G.Y.H. Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial. Am. J. Med. 2017; 130(12): 1388-96.